Rossi Dino A received 1,658 derivative securities of Krystal Biotech, Inc. across two transactions dated September 14, 2026, with each recorded at $0 per share. The transaction code identifies the entries as awards, allowing investors to distinguish them from open-market purchases, sales or other insider activity.

Key Highlights

  • The two transactions were dated September 14, 2026.
  • Each transaction carried a recorded price of $0 per share.
  • Both entries used SEC transaction code A, which denotes an award or grant.

The securities were issued across two separate transactions. The transactions were dated September 14, 2026, and each was recorded at $0 per share. Krystal Biotech, Inc. is identified in the transaction record as KRYS. It distinguishes the 1,658 securities from transactions coded as open-market purchases or sales. The $0 per-share entry reflects the recorded transaction price for the awards. The activity involved derivative securities rather than common stock.